Correction: Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma.

Kurata K., James-Bott A., Tye MA., Yamamoto L., Samur MK., Tai Y-T., Dunford J., Johansson C., Senbabaoglu F., Philpott M., Palmer C., Ramasamy K., Gooding S., Smilova M., Gaeta G., Guo M., Christianson JC., Payne NC., Singh K., Karagoz K., Stokes ME., Ortiz M., Hagner P., Thakurta A., Cribbs A., Mazitschek R., Hideshima T., Anderson KC., Oppermann U.

DOI

10.1038/s41408-023-00793-y

Type

Journal article

Journal

Blood cancer j

Publication Date

07/02/2023

Volume

13

Permalink Original publication